KeyCi’s dermatologically tested lineup emphasizes clean formulations—vegan, cruelty-free, alcohol-free, and paraben-free—while being backed by pharmaceutical-grade research and FDA approval
The trial met its primary endpoint, with the combination therapy demonstrating a “statistically significant and clinically meaningful” improvement in radiographic progression-free survival
The study hit its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in radiographic progression-free survival (rPFS) compared to placebo plus XTANDI
The Clear Lake facility marks Clariant’s first U.S. site dedicated to PEG excipient production
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The deal also includes upfront licensing fees and milestone-based payments from Lupin to Zydus
The initiative comes through a collaboration with Asia’s oldest latex condom manufacturer
Cadila Pharmaceuticals’ journey has been marked by several milestones, including the development of indigenous formulations, expansion into global markets, and the creation of robust manufacturing and R&D capabilities
One task, one interaction, one pair, experts advocate
Subscribe To Our Newsletter & Stay Updated
